We found that CD1d overexpression in MC38 tumor cells showed no influence on anti-tumor efficacy of iNKT cells, and knockdown of Vcam1 efficiently elevated anti-tumor efficacy of iNKT cells in CD1d expressing MC38 tumor models (Fig. 8r–u). Here, VCAM1 is linked to neoplasm.